Is it safe?
Can CYTK take a bad year?
Cytokinetics, Incorporated holds $890M more cash than debt, and is burning $145M a quarter, about 2.0 years of cover.
$890M
Net cash
- Net debt / EBITDA
- net cash
Net debt / EBITDA · no net borrowings to measure against earnings
- Altman Z-score
- -1.02
Altman Z-score · distress zone, below 1.8
- Cash runway
- 2.0 years
Cash runway · burning $145M a quarter at the current rate
Details›
- Total debtQ2 2026
- $276M
- Cash and short-term investments
- $1.17B
- Net cash
- $890M
- EBITDA, trailing twelve months
- −$695M
- Operating profit, trailing twelve months
- −$708M
- Annualised volatilitytwo years of daily moves
- 55%
- Worst drawdown on file
- −72%
- Below its 52-week high
- −6.7%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.